Matches in Nanopublications for { ?s ?p "[Our finding of wide expression of DR4/DR5 in ESFT in vivo, in combination with their high sensitivity to TRAIL in vitro and the reported lack of toxicity of TRAIL in mice and monkeys, suggests that TRAIL may be a novel effective agent in the treatment of ESFTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 2 of
2
with 100 items per page.
- NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_assertion description "[Our finding of wide expression of DR4/DR5 in ESFT in vivo, in combination with their high sensitivity to TRAIL in vitro and the reported lack of toxicity of TRAIL in mice and monkeys, suggests that TRAIL may be a novel effective agent in the treatment of ESFTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP427550.RADrz_ZmdVAHQLQLEBPstMXL_a7wo9ZAQDEMoAsY9MsYo130_provenance.
- NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_assertion description "[Our finding of wide expression of DR4/DR5 in ESFT in vivo, in combination with their high sensitivity to TRAIL in vitro and the reported lack of toxicity of TRAIL in mice and monkeys, suggests that TRAIL may be a novel effective agent in the treatment of ESFTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.